The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/792774
CAPABILITIES COMPATIBILITY DEVELOPMENT EXPERTISE RELIABILITY K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2017 CMO LEADERSHIP AWARDS WINNERS 60 LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2017 QUALITY Company Profiles DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre- Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: aseptic fill/finish, capsules, cartridges, controlled substances, cyto- toxic & high potency compounds, gels, injectables, liquids, ophthalmics, parenterals: large volume, parenterals: small volume, semisolids, solid dose, solutions & suspensions, sterile, syringes: pre- filled, spray drying, micronization, milling, azide chemistry, phosgenation, controlled substances "I'm delighted to receive the CMO Leadership award for Siegfried with recognition in all core categories. Siegfried transformed over the past five years into a global network having nine sites worldwide, offering fully integrated drug sub- stance and drug product services. We provide cus- tomers superior products and tailor-made services to support their entire value chains. Whether it's custom development, producing APIs, controlled substances, or drug products (solid or sterile liq- uids), you can expect more with Siegfried." DRUG TYPE: Pharmaceuticals RUDOLF HANKO CEO CATEGORIES WON: Siegfried Pennsville, NJ www.siegfried.ch Contact: Sandra Cernick Email: sales@siegfried.ch Key locations: Switzerland; Pennsville, NJ, USA; Irvine, CA, USA; China; France; Germany; Malta INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on- time, reputation, right first time, state-of-the-art, strength of science DRUG LIFE CYCLE STAGES: Research & Development: Pre-Clinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics SERVICES & CAPABILITIES: capsules, cytotoxic & high potency compounds, liquids, powders: non- sterile, solid dose, solutions & suspensions "Thank you to our customers for recognizing us in the 2017 CMO Leadership Awards! We're honored to receive this award for the fourth time. The Awards truly reflect the efforts of our entire 2500+ staff in China and USA, working together relentlessly to deliver high quality and best-in- class services enabling our customers to advance their therapies from preclinical to commercial faster and more efficiently." DRUG TYPE: Pharmaceuticals MINZHANG CHEN CEO CATEGORIES WON: STA Pharmaceuticals A WuXi AppTec Company Shanghai, China www.wuxiapptec.com Phone: 86 (21) 2066-3734 Contact: Yu Lu Email: yu.lu@wuxiapptec.com Key locations: Shanghai, China; Changzhou, China; Wuxi City, China; San Diego, CA, USA DRUG LIFE CYCLE STAGES: Research & Development: Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production SERVICES & CAPABILITIES: non-sterile, proteins, vaccines "We are honored to be recognized by the industry in the CMO Leadership Awards. Innovation is at the heart of our organization in the quest to help our clients bring their medicines to market efficiently and reliably. To receive this acknowl- edgement by the CMO Leadership Awards is a tes- tament to the hard work of not just our scientists but everyone across the organization." DRUG TYPE: Biopharmaceuticals STEVE BAGSHAW CEO CATEGORIES WON: FUJIFILM Diosynth Biotechnologies Morrisville, NC www.fujifilmdiosynth.com Phone: +1 979 337 4400 Key locations: Billingham, UK; College Station, TX, USA